Journal Contents :   №15 3 2013

International experience

6 MONTHS VERSUS 12 MONTHS OF ADJUVANT TRASTUZUMAB FOR PATIENTS WITH HER2-POSITIVE EARLY BREAST CANCER (PHARE): A RANDOMISED PHASE 3 TRIAL

№15 3 2013 20

Review

LEUKEMIC BLAST CELLS AND UP TO DATE HIERARCHY MODEL OF NORMAL HEMOPOIESIS

Authors:Ukrainskaya N.I. Koval S.V. Poludnenko L.Yu. Gluzman D.G. ... №15 3 2013 2

THE CYTOLOGICAL DIAGNOSIS OF OVARIAN TUMORS

Authors:Yaroshuk T.M. Bolgova L.S. №15 3 2013 3

Original investigations

MODIFICATION OF EPITHELIAL-MESENCHYMAL TRANSITION IN BREAST CANCER CELLS BY MEANS OF THEIR CO-CULTIVATION WITH FIBROBLASTS AND BONE MARROW CELLS

Authors:Bezdenezhnykh N.O. Semesiuk N.I. Lykhova O.O. Zhylchuk V.E. ... №15 3 2013 4

REDOX-DEPENDENT MECHANISMS OF TUMOR INTERACTION WITH BONE MARROW

Authors:Sidorik E.P. №15 3 2013 2

RELATIONS BETWEEN SERUM AND TUMOR FERRITIN CONCENTRATIONS WITH SENSITIVITY TO NEOADJUVANT CHEMOTHERAPY IN BREAST CANCER PATIENTS

Authors:Chekhun V.F. Antipova S.V. Shepil O.V. №15 3 2013 3

THE RELATIVE SIGNIFICANCE OF INDIVIDUAL RISK FACTORS OF BREAST CANCER IN WOMEN OF DIFFERENT AGES

Authors:Tymovska Y.O. Anikusko M.F. Sobchenko S.O. №15 3 2013 5

CHARACTERISTICS OF BONE MARROW PROGENITOR CELLS AS AN CRITERION FOR EVALUATING INDIVIDUAL RESPONSE OF PATIENTS WITH CHRONIC MYELOID LEUKEMIA TO THERAPY WITH TYROSINE KINASE INHIBITOR

Authors:Diachenko M. Zhaleiko I. Dyagil I. Perekhrestenko T. ... №15 3 2013 2

TUMOR CELLS IN REGIONAL LYMPH NODES OF GASTRIC CANCER PATIENTS WITH N0 CATEGORY AND THEIR CLINICAL RELEVANCE

Authors:Antonov E.O. Gumenyuk L.D. Mamontova L.A. Osinsky D.S. №15 3 2013 3

MEDIASTINAL MALIGNANT NON-CHROMAFFIN PARAGANGLIOMAS: DIAGNOSIS AND CHOICE OF TREATMENT

Authors:Zakharychev V.D. Ganul A.V. Semyvolos A.V. Krotevitch M.S. №15 3 2013 1

Opinion

NON-HODGKIN’S MALIGNANT MARGINAL ZONE LYMPHOMA: DIAGNOSIS AND TREATMENT

Authors:Ponomarova O.V. Yurchenko O.V. №15 3 2013 3